North America commanded the largest share of the global real-world evidence solutions market in 2018, followed by Europe and Asia-Pacific.

With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also raised. Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost effectiveness outside the controlled environment and homogeneous setting of a clinical trial i.e. Randomized Clinical Trials (RCT) to inform decision making processes.

The global real world evidence solutions market is expected to reach $1.64 billion by 2024 from an estimated $0.87 billion in 2019, at a CAGR of 15.0% from 2019 to 2024.

Request Sample Copy of Report @ https://www.meticulousresearch.com/request-sample-report/cp_id=4954

Real World Evidence (RWE) Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) - Global Forecast to 2024

The shift towards value-based care, growing focus on personalized health care, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making supports the growth of RWE solutions market. However, reluctance to rely on real-world studies, uneven quality of real-world data sources, and lack of standards may hamper the growth of the overall RWE solutions market to some extent.

The global real-world evidence solutions market is segmented on the basis of component into data sets, and consulting/ services. The data sets market is further segmented into disparate data sets (EMR/EHR/clinical data, pharmacy data, product/disease registries, claims & billing data, other data) and integrated data sets. On the basis of application, this market is segmented into drug development & approvals (oncology, cardiovascular disease, neurology, immunology, and other therapeutic areas), market access &reimbursement/coverage decisions, medical device development & approvals, clinical decision-making, and other applications. This report also analyzed different end users of RWE solutions which are categorized into pharmaceutical, biotechnology & medical device companies, healthcare payers, healthcare providers, and other end users.

Browse in depth of report @ https://www.meticulousresearch.com/product/Real-World-Evidence-Solutions-Market-4954/

North America comprises the largest share as well as fastest growth

North America commanded the largest share of the global real-world evidence solutions market in 2018, followed by Europe and Asia-Pacific. The largest share and fastest growth of this region is mainly attributed to significant availability of real-world data sets, growing focus on value-based care, rising R&D expenditure by the biopharma companies, greater emphasis on early drug/device development and approvals, presence of major RWE players in the region, stringent regulations for drug approvals, and supporting government policies (implementation of 21st Century Cures Act (December 2016) and FDA's new 2019 strategic Framework for RWE (December 2018) in the U.S).

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2015-2019). The key players profiled in the real-world evidence solutions market research report include Anthem, Inc., Clinigen Group plc, Cognizant, IBM Corporation, ICON plc, IQVIA, Optum,Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., Pharmaceutical Product Development, LLC., SAS Institute Inc., and Syneos Health.

TOP 10 COMPANIES IN REAL WORLD EVIDENCE SOLUTIONS MARKET
https://meticulousblog.org/top-10-companies-in-real-world-evidence-solutions-market/

Market Study
1. Introduction
1.1. Market Definition
1.2. Currency and Limitation
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Geriatric Population and Burden of Chronic Diseases
4.2.2. Shift Towards Value-Based Care
4.2.3. Growing Focus on Personalized Health Care
4.2.4. Delays in Drug Development and the Subsequent increase in Development Costs
4.2.5. Expanding Use of RWE for Regulatory Decision Making
4.3. Restraint
4.3.1. Uneven Data Quality & Reluctance to Rely on Real-World Studies
4.4. Opportunities
4.4.1. Growth Opportunities in Emerging Markets
4.4.2. Rising Focus on End-To-End RWE Services
4.4.3. Emerging Roles of Wearable Devices and AI in RWE
4.5. Challenge
4.5.1. Lack of Standardized Methodologies to Develop RWE

5. RWE Solutions Market, By Component
5.1. Introduction
5.2. Data Sets
5.2.1. Disparate Data Sets
5.2.1.1. EMR/EHR/Clinical Data
5.2.1.2. Claims & Billing Data
5.2.1.3. Pharmacy Data
5.2.1.4. Product/Disease Registries Data
5.2.1.5. Other Data
5.2.2. Integrated Data Sets
5.3. Consulting/ Services

Download Sample to continue to read @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954

Contact Us:
Meticulous Research
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

This release was published on openPR.